Cargando…

Progress in the photodynamic therapy treatment of Leishmaniasis

Leishmaniasis is a serious and endemic infectious disease that has been reported in more than 90 countries and territories. The classical treatment presents a series of problems ranging from difficulty in administration, development of resistance, and a series of side effects. Photodynamic therapy (...

Descripción completa

Detalles Bibliográficos
Autores principales: Vital-Fujii, D.G., Baptista, M.S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Divulgação Científica 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555448/
https://www.ncbi.nlm.nih.gov/pubmed/34730683
http://dx.doi.org/10.1590/1414-431X2021e11570
_version_ 1784591980272025600
author Vital-Fujii, D.G.
Baptista, M.S.
author_facet Vital-Fujii, D.G.
Baptista, M.S.
author_sort Vital-Fujii, D.G.
collection PubMed
description Leishmaniasis is a serious and endemic infectious disease that has been reported in more than 90 countries and territories. The classical treatment presents a series of problems ranging from difficulty in administration, development of resistance, and a series of side effects. Photodynamic therapy (PDT) has already shown great potential for use as a treatment for leishmaniasis that is effective and non-invasive, with very minor side effects. PDT can also be inexpensive and easy to administer. In this review, we will report the most recent developments in the field, starting with the chemical diversity of photosensitizers, highlighting important mechanistic aspects, and noting information that may assist in designing and developing new and promising photosensitizer molecules.
format Online
Article
Text
id pubmed-8555448
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Associação Brasileira de Divulgação Científica
record_format MEDLINE/PubMed
spelling pubmed-85554482021-11-05 Progress in the photodynamic therapy treatment of Leishmaniasis Vital-Fujii, D.G. Baptista, M.S. Braz J Med Biol Res Review Leishmaniasis is a serious and endemic infectious disease that has been reported in more than 90 countries and territories. The classical treatment presents a series of problems ranging from difficulty in administration, development of resistance, and a series of side effects. Photodynamic therapy (PDT) has already shown great potential for use as a treatment for leishmaniasis that is effective and non-invasive, with very minor side effects. PDT can also be inexpensive and easy to administer. In this review, we will report the most recent developments in the field, starting with the chemical diversity of photosensitizers, highlighting important mechanistic aspects, and noting information that may assist in designing and developing new and promising photosensitizer molecules. Associação Brasileira de Divulgação Científica 2021-10-29 /pmc/articles/PMC8555448/ /pubmed/34730683 http://dx.doi.org/10.1590/1414-431X2021e11570 Text en https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Vital-Fujii, D.G.
Baptista, M.S.
Progress in the photodynamic therapy treatment of Leishmaniasis
title Progress in the photodynamic therapy treatment of Leishmaniasis
title_full Progress in the photodynamic therapy treatment of Leishmaniasis
title_fullStr Progress in the photodynamic therapy treatment of Leishmaniasis
title_full_unstemmed Progress in the photodynamic therapy treatment of Leishmaniasis
title_short Progress in the photodynamic therapy treatment of Leishmaniasis
title_sort progress in the photodynamic therapy treatment of leishmaniasis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555448/
https://www.ncbi.nlm.nih.gov/pubmed/34730683
http://dx.doi.org/10.1590/1414-431X2021e11570
work_keys_str_mv AT vitalfujiidg progressinthephotodynamictherapytreatmentofleishmaniasis
AT baptistams progressinthephotodynamictherapytreatmentofleishmaniasis